Novoron Bioscience Competitors and Similar CompaniesClear all
CTI BioPharma's competitors and similar companies include Heron Therapeutics.
 CTI BioPharma CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers. |  Heron Therapeutics Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development. | |
Founding Date | Founding Date 1992 | Founding Date 1983 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Seattle, US HQ Köln, DE | Locations San Diego, US HQ |
Employees | Employees 2546% decrease | Employees 20333% decrease |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) 268.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $53.9m (FY, 2022) | Revenue (est.) $154.9m (FY, 2025) |
Cost of goods | Cost of goods $3.5m (FY, 2022) | Cost of goods $41.3m (FY, 2025) |
Gross profit | Gross profit $50.4m (FY, 2022) | Gross profit $113.6m (FY, 2025) |
Net income | Net income ($93m) (FY, 2022) | Net income ($20.2m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Heron Therapeutics
HQ
San Diego, US
Employees
203↓ 33% decrease
Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.
View company